Home > News > BioSante Pharmaceuticals To Present At Investor Conference
February 23rd, 2004
BioSante Pharmaceuticals To Present At Investor Conference
BioSante Pharmaceuticals announced today that Stephen M. Simes, its president and chief executive officer, is scheduled to present at the BIO CEO & Investor Conference at the Waldorf-Astoria Hotel in New York on Wednesday, February 25, at 9:30 a.m. EST. Mr. Simes will discuss BioSante's progress with its hormone therapy products and its nanotechnology-based drug and vaccine delivery systems.
More effective kidney stone treatment, from the macroscopic to the nanoscale April 17th, 2014
High-temperature plasmonics eyed for solar, computer innovation April 17th, 2014
INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014
Transparent Conductive Films and Sensors Are Hot Segments in Printed Electronics: Start-ups in these fields show above-average momentum, while companies working on emissive displays such as OLED are fading, Lux Research says April 17th, 2014